Cargando…
219. Outcomes with Low- vs. High-bioavailability Oral Antibiotics in Treatment of Uncomplicated Gram-Negative Bacteremia
BACKGROUND: High-bioavailability (HIGH-BIO) oral agents (i.e. trimethoprim-sulfamethoxazole, fluoroquinolones) are increasingly utilized for definitive treatment of uncomplicated gram-negative (UGN) bloodstream infections (BSI). Literature supports use of HIGH-BIO agents as step-down therapy, but fe...
Autores principales: | Cubillos, Ashley L, Chandler, Elisabeth, Murphy, Ian P, Castro, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643981/ http://dx.doi.org/10.1093/ofid/ofab466.421 |
Ejemplares similares
-
219. Clinical Outcomes of Early vs Late Oral Stepdown Therapy in the Management of Uncomplicated Gram-Negative Bacteremia
por: Michael, Amanda, et al.
Publicado: (2023) -
149. Short vs. Long Course of Antibiotics for Uncomplicated Gram-Negative Bacteremia
por: Go, James, et al.
Publicado: (2019) -
713 Short vs Long Courses of Antibiotic Treatment in Adults with Uncomplicated Gram-negative Bacteremia in a Tertiary Inistituition
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014) -
Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019) -
1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)